Effects bucindolol neurohormonal activation congestive heart failure effects beta-adrenergic blockade neurohormonal activation patients congestive heart failure men assessments hemodynamics supine peripheral renin norepinephrine levels months oral therapy bucindolol nonselective beta antagonist baseline plasma renin activity hemodynamic parameter norepinephrine levels weak correlation left ventricular end-diastolic pressure volume index pulmonary vascular resistance Plasma renin bucindolol therapy ng/ml/hour mean standard deviation whereas plasma norepinephrine unchanged pg/ml wide diversity norepinephrine response reduction levels patients elevation others plasma norepinephrine heart rate vs beta-adrenergic blockade neurohormonal antagonism receptor level changes metaiodobenzylguanidine uptake bucindolol therapy unchanged adrenergic uptake norepinephrine beta-blocker therapy reductions plasma renin activity presence beta blockade response renin norepinephrine levels long-term bucindolol therapy patients hemodynamic status chi-square renin norepinephrine 